🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
Dolutegravir (DTG) and lamivudine (3TC) are indicated in combination with o...
Status
Completed
Location
GSK Investigational Site
Start Date
2016-05
Trial ID
NCT02738931
Protocol Title: DOLCE: Dolutegravir-Lamivudine for naïve HIV-Infected Patie...
Status
Completed
Location
Fundación Huésped
Start Date
2021-05-17
Trial ID
NCT04880395
This study is designed to demonstrate the non-inferior antiviral activity o...
Status
Completed
Location
GSK Investigational Site
Start Date
2013-08-22
Trial ID
NCT01910402
Treatments Being Tested
MODERATO is a phase III, open-label, randomized, multicenter, non-inferiori...
Status
Unknown
Location
Hôpital de jour, Service des maladies infectieuses, CHU Sourô Sanou
Start Date
2020-09-21
Trial ID
NCT04022967
Protocol Number: FH-94 Study Objetives: Primary: * To evaluate the virol...
Status
Not Yet Recruiting
Location
Hospital General de Agudos Dr. Cosme Argerich
Start Date
2026-06-15
Trial ID
NCT07616739
The First Long-Acting Injectable Regimen (FLAIR) study is being conducted t...
Status
Active Not Recruiting
Location
GSK Investigational Site
Start Date
2016-10-27
Trial ID
NCT02938520
Dolutegravir (DTG, GSK1349572) is a next-generation integrase inhibitor (IN...
Status
Completed
Location
GSK Investigational Site
Start Date
2012-06
Trial ID
NCT01622790
This is a single-center, open label study to identify adherence levels of c...
Status
Completed
Location
HIV/AIDS Clinical Research Unit / University of Pittsburgh
Start Date
2020-08-31
Trial ID
NCT04302896
Patients who developed metabolic syndrome after initiation of HIV treatment...
Status
Recruiting
Location
Hospital de infectología, Centro Médico Nacional La Raza
Start Date
2024-08-14
Trial ID
NCT06602622
Treatments Being Tested
This will be a Phase IIIb Clinical Trial, an international multicenter, ran...
Status
Recruiting
Location
Instituto Tropical de Doenças Infecciosas Manaus
Start Date
2025-09-18
Trial ID
NCT06497465